Breaking News
Get 50% Off 0
Get a powerful boost to your portfolio: August's freshest AI-picked stocks
Pick Stocks with AI
Close

Candel Therapeutics Inc (CADL)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Candel Therapeutics's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
6.29 -0.16    -2.48%
01/08 - Closed. Currency in USD
After Hours
6.35
+0.06
+0.95%
22:30:57 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 592,079
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 6.11 - 6.34
Candel Therapeutics 6.29 -0.16 -2.48%

Candel Therapeutics Inc Company Profile

 
Get an in-depth profile of Candel Therapeutics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

38

Equity Type

ORD

Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies for the cancer patients. It develops CAN-2409, which is in Phase III clinical trials for the treatment of prostate cancer; Phase II clinical trials for the treatment of pancreatic cancer; and Phase II clinical trials for the treatment of non-small cell lung cancer (NSCLC). The company is also developing CAN-3110, which is in Phase Ib clinical trials for the treatment of recurrent high-grade glioma. In addition, it develops the?enLIGHTEN Discovery Platform, a systematic, iterative herpes simplex virus based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapy candidates for solid tumors. The company was formerly known as Advantagene, Inc. and changed its name to Candel Therapeutics, Inc. in November 2020. Candel Therapeutics, Inc. was incorporated in 2003 and is headquartered in Needham, Massachusetts.

Contact Information

Address 117 Kendrick Street Suite 450
Needham, 02494
United States
Phone 617 916 5445
Fax -

Top Executives

Name Age Since Title
Paul B. Manning 67 2018 Independent Chairman
Paul-Peter Tak 61 2020 President, CEO & Director
Charu Aggarwal - - Member of Scientific Advisory Board
James Patrick Allison - 2021 Member of Research Advisory Board
Daniel H. Sterman - - Member of Scientific Advisory Board
E. Antonio Chiocca - - Member of Scientific Advisory Board
Steven M. Albelda - - Member of Scientific Advisory Board
Christopher Martell 45 2018 Independent Director
Roy Steven Herbst 61 2021 Member of Research Advisory Board
Scott Eggener - - Member of Scientific Advisory Board
Adam Kibel - - Member of Scientific Advisory Board
Henry Brem 71 2021 Member of Research Advisory Board
Elizabeth M. Jaffee - 2025 Member of Research Advisory Board
Philip W. Kantoff 70 2021 Member of Research Advisory Board
Padmanee Sharma - 2021 Member of Research Advisory Board
Renee M. Gaeta 44 2022 Independent Director
Diem Nguyen 52 2021 Independent Director
Edward John Benz 79 2017 Member of Research Advisory Board & Independent Director
Gary J. Nabel 70 2022 Member of Research Advisory Board & Independent Director
Joseph C. Papa 69 2022 Independent Director
Nicoletta Loggia 57 2023 Independent Director
Mahalakshmi Radhakrishnan 55 2025 Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CADL Comments

Write your thoughts about Candel Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email